Astellas - (Contractor) - Northbrook, IL
posted 4 months ago
The Portfolio Operations Lead for Early Development Oncology at Astellas is a pivotal role that oversees and provides strategic direction across pre- and post-proof of concept (POC) development programs. This position is integral to the execution of multiple cross-therapeutic, global clinical drug development programs, which may encompass various therapeutic areas such as Oncology, Immuno-Oncology, rare diseases, and Biopharma, including cell and gene therapies. The role may also extend to managing digital and combination drug-device therapeutics. In this capacity, the Portfolio Operations Lead is responsible for ensuring consistent strategic input and operational insight across assets in their primary focus area of development. This includes oversight of Clinical Operations Leads and core development plans, such as the Integrated Evidence Generation Plan (iEGP), Global Development Plan (GDP), Clinical Development Plan (CDP), and patient-focused strategies. The position may also involve representing Clinical Operations in due diligence activities, providing expert input on Clinical Development Plans, operational strategies, and budget and timeline assumptions. As a member of the extended Clinical Operations leadership team, the Portfolio Operations Lead contributes to departmental structure, budget and resourcing strategies, and the development and oversight of global processes and procedures. Additionally, this role includes training, coaching, and mentoring of staff, both direct and indirect, ensuring that clinical development teams adhere to established operational standards, approved budgets, and timelines. The Portfolio Operations Lead is also tasked with proactively identifying and managing operational risks that may arise during program and trial conduct, engaging in strategic problem-solving and contingency planning with key cross-functional leadership and stakeholders to ensure timely completion of trials and program deliverables. This position is considered a Subject Matter Expert in process improvements, clinical program development strategy, and clinical trial execution, and plays a crucial role in fostering collaboration between Early and Late Stage Portfolio Operations Leads.